1
Supplement$59.99· checked May◆ Editor's Pick
Genex Formulas NMN 1000mg
Increased NAD Levels & Healthy Aging. On sale for a dose that does something.
Visit source →
May be an affiliate link, see footer.
1
Upvotes
1
Verified
1
Comments
Evidence
4/5
Multiple RCTs (randomized controlled trials) confirm that oral NMN reliably raises blood NAD+ levels in humans. Evidence for downstream clinical benefits — improved muscle function, insulin sensitivity, and fatigue — exists but is modest, with most trials being small (n<50) and short-term, and few replicating the same endpoint convincingly.
Mechanism
NMN (nicotinamide mononucleotide) is a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme central to cellular energy metabolism, DNA repair, and sirtuin activation. Oral NMN is converted to NMN or NR (nicotinamide riboside) in the gut before entering cells, where it raises tissue NAD+ levels that decline with age.
Best evidence type
Randomized trial
Sources
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.GeroScience · 2023 · RCT
“In animal studies, β-nicotinamide mononucleotide (NMN) supplementation increases nicotinamide adenine dinucleotide (NAD) concentrations and improves healthspan and lifespan with great safety.”
- Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.Science (New York, N.Y.) · 2021 · RCT
“In rodents, obesity and aging impair nicotinamide adenine dinucleotide (NAD+) biosynthesis, which contributes to metabolic dysfunction.”
- Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.Scientific reports · 2023 · RCT
“Many animal studies have shown that oral administration of the nicotinamide adenine dinucleotide (NAD+) precursor nicotinamide mononucleotide (NMN) prevents the reduction of NAD+ levels in organs and tissues, helping alleviate aging-related”
- Effects of Nicotinamide Mononucleotide Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Current pharmaceutical biotechnology · 2025 · Meta-analysis
“INTRODUCTION: Nicotinamide Mononucleotide (NMN) has gained attention as a precursor to Nicotinamide Adenine Dinucleotide (NAD+) in recent years, commonly utilized in anti-aging therapies.”
Caveats
Most human RCTs are underpowered and industry-funded, limiting confidence in effect sizes. The optimal dose is unclear; 1000 mg/day is on the higher end of studied doses, but dose-response data in humans is thin. Long-term safety data beyond 12 weeks is sparse. NMN's advantage over the cheaper precursor NR (nicotinamide riboside) has not been established in head-to-head trials. Anti-aging or longevity claims rest almost entirely on animal data and have not been demonstrated in humans.
✓
Tried it? Verify this find to help others know it works. Members can verify, free to join.
0 comments
Be the first to comment.
EOD publishes opinions and summaries of research about supplements, services, and protocols. It is not medical advice. Consult a qualified healthcare provider before changing your supplement, exercise, sleep, or medication regimen.
Some outbound links on EOD are affiliate links. If you buy through them we may earn a small commission, at no extra cost to you. It never influences what we publish or how it's ranked. Full disclosure.
EOD · 123 Placeholder Street, New York, NY 10001
END OF DAY · MMXXVI